Welcome to INSPECT- Indiana's Prescription Monitoring Program!
ALL REPORTING PHARMACIES:
ATTENTION- Effective July 1, 2016, pursuant to Ind. Code 25-26-13-4, ephedrine and pseudoephedrine, when dispensed via prescription, are each considered a "controlled substance" for the purposes of the INSPECT program. All prescription dispensations of these drugs must be reported to INSPECT. Over-the-counter purchases are not reported to INSPECT and must still be processed through NPLEx.
The Inspect Helpdesk is supported and maintained by Appriss, Inc. which will promptly provide assistance.
Phone: (844) 446-4767
Please be sure to provide your Contact Information (Name, Organization, Phone, and Email) along with your description of the incident.